In contrast, sRAGE, which functions as a decoy receptor by neutralizing the effects of AGEs on mitogen-activated protein kinase activation, mitigating oxidative stress, and inhibiting proinflammatory signalling cascades [13,37] was reduced in OSA patients compared with controls (Table 2). The gene discussed is AGER; the disease is obstructive sleep apnea syndrome.